Our platform combines de novo and scaffold-guided design with complementary generative AI models. Custom filters built into the de novo pipeline - tuned on our own experimental data - rank and triage designs so only the most progressable candidates advance. We focus on developable miniproteins, whose modular format enables flexible, multispecific architectures.
Stability
Stabilized by strong hydrophobic core and/or disulfide bonds; resistant to protease degradation, hydrolysis, and oxidation.
Developability
Modular format enables multi-epitope targeting via fusions. PK/PD is precisely tunable through format engineering, sustained-release, or chemical modification. Low-cost, versatile manufacturing: synthetic and recombinant.
Efficacy
Outstanding (subnanomolar) affinity. Excellent tissue penetration due to small size (max 70 amino acids)
Safety
Up to 10,000x selectivity due to large interaction surface. No harmful breakdown products.
Low immunogenicity
Small size and protease resistance minimize the risk of anti-drug antibody (ADA) formation.
Stability
Stabilized by strong hydrophobic core and/or disulfide bonds; resistant to protease degradation, hydrolysis, and oxidation.
Developability
Modular format enables multi-epitope targeting via fusions. PK/PD is precisely tunable through format engineering, sustained-release, or chemical modification. Low-cost, versatile manufacturing: synthetic and recombinant.
Efficacy
Outstanding (subnanomolar) affinity. Excellent tissue penetration due to small size (max 70 amino acids)
Safety
Up to 10,000x selectivity due to large interaction surface. No harmful breakdown products.
Low immunogenicity
Small size and protease resistance minimize the risk of anti-drug antibody (ADA) formation.
Designed for developability. Engineered with precision.
Structure-Guided Design Strategy
We analyze target structure, accessible interaction surfaces, functional hotspots, and relevant ligand interactions to provide a rational foundation for precise, high-affinity molecular design.
AI-Driven Miniprotein Design and Evaluation
We perform comprehensive structural and functional analysis to identify key interaction sites-such as binding patches and hotspots- on the target protein. This process includes the extraction and alignment of relevant secondary structural motifs from known ligands, forming the foundation for designing high-affinity, structure-based interactions.
Experimental Screening and Functional Validation
Designed scaffolds are evaluated through library-based screening and direct testing to identify active candidates. Selected hits are then validated in functional cell-based assays to confirm target engagement and the desired biological effect.
Precision Engineering
Lead candidates are optimized for affinity, selectivity, and function using advanced display technologies. Next-generation sequencing and machine-learning-assisted data analysis enable efficient exploration and expansion of sequence space, guiding the design of improved variants.
Rapid In Vivo Proof of Concept
Promising candidates advance into in-house in vivo studies for early assessment of biological activity, exposure, and translational potential, enabling faster proof-of-concept decisions.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.